Add to ORKGThe study seeks to retrospectively analyze the outcome of microvascular decompression (MVD) for hemifacial spasm (HFS) in 121 patients treated between January 1998 and June 1999. The review seeks to detect any differences between patients previously treated with botulinum toxin injections (Botox) and those never exposed to the drug prior to surgery
Hemifacial Spasm (HFS) can be a functionally debilitating condition hampering or preventing patients...
Objective To analyze the operating points and evaluate the therapeutic efficacy and safety of microv...
Although microvascular decompression (MVD) is a reliable treatment for hemifacial spasm (HFS), posto...
This study seeks to analyze the outcome of microvascular decompression (MVD) for hemifacial spasm (H...
To assess the safety and efficacy of microvascular decompression (MVD) in the treatment of hemifacia...
In order to observe the change of the clinical results after Microvascular Decompression(MVD), we fo...
We analyzed the records of 1,169 patients with hemifacial spasm (HFS) who underwent microvascular de...
BACKGROUND: Microvascular decompression is the most reliable treatment for HFS, but it may cause com...
OBJECTIVE: The objective of this study was to investigate the outcome of reoperation for persistent ...
<p><b>Objective:</b> Microvascular decompression (MVD) for hemifacial spasm (HFS) provides resolutio...
Objective: To explore the clinical characteristics of patients with persistent or recurrent hemifaci...
Objective: Although microvascular decompression (MVD) is a reliable treatment for hemifacial spasm (...
Hemifacial spasm is usually treated with botulinum toxin A (BTX-A) injections, a proven symptomatic ...
BACKGROUND: Microvascular decompression (MVD) for hemifacial spasm (HFS) is regarded as the gold-sta...
There is a 10-15% incidence of hemifacial spasm (HFS) recurrence following initial treatment with m...
Hemifacial Spasm (HFS) can be a functionally debilitating condition hampering or preventing patients...
Objective To analyze the operating points and evaluate the therapeutic efficacy and safety of microv...
Although microvascular decompression (MVD) is a reliable treatment for hemifacial spasm (HFS), posto...
This study seeks to analyze the outcome of microvascular decompression (MVD) for hemifacial spasm (H...
To assess the safety and efficacy of microvascular decompression (MVD) in the treatment of hemifacia...
In order to observe the change of the clinical results after Microvascular Decompression(MVD), we fo...
We analyzed the records of 1,169 patients with hemifacial spasm (HFS) who underwent microvascular de...
BACKGROUND: Microvascular decompression is the most reliable treatment for HFS, but it may cause com...
OBJECTIVE: The objective of this study was to investigate the outcome of reoperation for persistent ...
<p><b>Objective:</b> Microvascular decompression (MVD) for hemifacial spasm (HFS) provides resolutio...
Objective: To explore the clinical characteristics of patients with persistent or recurrent hemifaci...
Objective: Although microvascular decompression (MVD) is a reliable treatment for hemifacial spasm (...
Hemifacial spasm is usually treated with botulinum toxin A (BTX-A) injections, a proven symptomatic ...
BACKGROUND: Microvascular decompression (MVD) for hemifacial spasm (HFS) is regarded as the gold-sta...
There is a 10-15% incidence of hemifacial spasm (HFS) recurrence following initial treatment with m...
Hemifacial Spasm (HFS) can be a functionally debilitating condition hampering or preventing patients...
Objective To analyze the operating points and evaluate the therapeutic efficacy and safety of microv...
Although microvascular decompression (MVD) is a reliable treatment for hemifacial spasm (HFS), posto...